Description: NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. The company offers animal health pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine hcl, s-methoprene, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, carprofen, fenbendazole, and xylazine hydrochloride. It also offers human health pharmaceutical ingredients comprising of nitazoxanide and atovaquone; and intermediates and specialty chemicals consisting of trimethyl, triazacylononane, and ethyl glucamine. In addition, the company provides finished dosage forms comprising of diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Home Page: www.nglfinechem.com
301, E Square
Mumbai,
400057
India
Phone:
91 22 4084 2222
Officers
| Name | Title |
|---|---|
| Mr. Rahul Jayant Nachane | CEO, MD, Chief Ethics Counsellor & Executive Director |
| Mr. Rajesh Narayan Lawande | Whole Time Director & CFO |
| Ms. Pallavi Pednekar | Company Secretary & Compliance Officer |
| Mr. Ahaan Nachane | Vice President |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 27.4712 |
| Price-to-Book MRQ: | 4.0526 |
| Price-to-Sales TTM: | 3.1988 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 682 |